The 21st Century Cures Act, signed into law on December 13, 2016, includes several provisions related to regenerative medicine. Regenerative medicine covers a wide range of innovative products including cell therapies, therapeutic tissue engineering products, human...
Pearl Pathways is a proud sponsor of the upcoming Indiana Regenerative Medicine Symposium entitled “Regulatory Pathways for Regenerative Medicine: Cell and Biological Therapeutics”. This two day event will include four sessions on Day 1 and an opportunity to register...
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?